Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID-19: Daily Top 10 Papers

  Breast Cancer

  Free Subscription


1 Am J Surg
1 Ann Oncol
5 Ann Surg Oncol
4 BMC Cancer
1 Br J Cancer
2 Breast Cancer (Dove Med Press)
3 Breast Cancer Res
7 Breast Cancer Res Treat
1 Breast J
1 Cancer
4 Cancer Epidemiol Biomarkers Prev
1 Cancer Lett
1 Cancer Res
1 Carcinogenesis
22 Clin Breast Cancer
3 Clin Cancer Res
2 Eur J Cancer
1 Int J Cancer
1 J Biol Chem
1 J Clin Oncol
3 NPJ Breast Cancer
1 Oncogene
2 PLoS One
1 Radiology

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    Am J Surg

  1. SARGENT RE, Vazquez E, Kang I, Lu J, et al
    Factors associated with relapse-free survival after neoadjuvant chemotherapy for breast cancer at a safety net medical center.
    Am J Surg. 2021 Nov 16. pii: S0002-9610(21)00676.
    PubMed         Abstract available

    Ann Oncol

  2. SPRING L, Matikas A, Bardia A, Foukakis T, et al
    Adjuvant abemaciclib for high-risk breast cancer: the story continues.
    Ann Oncol. 2021;32:1457-1459.

    Ann Surg Oncol

  3. TONNESON JE, Hoskin TL, Day CN, Durgan DM, et al
    Impact of the COVID-19 Pandemic on Breast Cancer Stage at Diagnosis, Presentation, and Patient Management.
    Ann Surg Oncol. 2021 Nov 23. pii: 10.1245/s10434-021-11088.
    PubMed         Abstract available

  4. CADILI L, DeGirolamo K, Ma CS, Chen L, et al
    The Breast Cancer Patient Experience of Telemedicine During COVID-19.
    Ann Surg Oncol. 2021 Nov 24. pii: 10.1245/s10434-021-11103.
    PubMed         Abstract available

  5. MITTAL A, Deo S, Gogia A, Batra A, et al
    ASO Visual Abstract: Profile of Pathogenic Mutations and Evaluation of Germline Genetic Testing Criteria in Consecutive Breast Cancer Patients Treated at a North Indian Tertiary Care Center.
    Ann Surg Oncol. 2021 Nov 25. pii: 10.1245/s10434-021-10967.

  6. LUEHMANN N, Ascha M, Chwa E, Hackenberger P, et al
    ASO Visual Abstract: A Single Center Study of Adherence to Breast Cancer Screening Mammography Guidelines by Transgender and Non-Binary Patients.
    Ann Surg Oncol. 2021 Nov 23. pii: 10.1245/s10434-021-11038.

  7. FU M, Chen Q, Zeng L, Hong T, et al
    Prognosis Comparison Between Nipple-Sparing Mastectomy and Total Mastectomy in Breast Cancer: A Case-Control Study After Propensity Score Matching.
    Ann Surg Oncol. 2021 Nov 20. pii: 10.1245/s10434-021-11044.
    PubMed         Abstract available

    BMC Cancer

  8. KLEIN I, Kalichman L, Chen N, Susmallian S, et al
    A comprehensive approach to risk factors for upper arm morbidities following breast cancer treatment: a prospective study.
    BMC Cancer. 2021;21:1251.
    PubMed         Abstract available

  9. XIN Y, Shen G, Zheng Y, Guan Y, et al
    Immune checkpoint inhibitors plus neoadjuvant chemotherapy in early triple-negative breast cancer: a systematic review and meta-analysis.
    BMC Cancer. 2021;21:1261.
    PubMed         Abstract available

  10. SHI Y, Liu C
    Circular RNA hsa_circ_0043278 inhibits breast cancer progression via the miR-455-3p/EI24 signalling pathway.
    BMC Cancer. 2021;21:1249.
    PubMed         Abstract available

  11. MASUDA N, Tamura K, Yasojima H, Shimomura A, et al
    Phase 1 trial of entinostat as monotherapy and combined with exemestane in Japanese patients with hormone receptor-positive advanced breast cancer.
    BMC Cancer. 2021;21:1269.
    PubMed         Abstract available

    Br J Cancer

  12. JAGGUPILLI A, Ly S, Nguyen K, Anand V, et al
    Metabolic stress induces GD2(+) cancer stem cell-like phenotype in triple-negative breast cancer.
    Br J Cancer. 2021 Nov 22. pii: 10.1038/s41416-021-01636.
    PubMed         Abstract available

    Breast Cancer (Dove Med Press)

  13. MEIJER SE, Klebanov-Akopyn O, Pavlov V, Laks S, et al
    Detection of Minimal Residual Disease in the Peripheral Blood of Breast Cancer Patients, with a Multi Marker (MGB-1, MGB-2, CK-19 and NY-BR-1) Assay.
    Breast Cancer (Dove Med Press). 2021;13:617-624.
    PubMed         Abstract available

  14. AYOUB NM, Fares M, Marji R, Al Bashir SM, et al
    Programmed Death-Ligand 1 Expression in Breast Cancer Patients: Clinicopathological Associations from a Single-Institution Study.
    Breast Cancer (Dove Med Press). 2021;13:603-615.
    PubMed         Abstract available

    Breast Cancer Res

  15. BARBER LE, Zirpoli GR, Cozier YC, Rosenberg L, et al
    Neighborhood disadvantage and individual-level life stressors in relation to breast cancer incidence in US Black women.
    Breast Cancer Res. 2021;23:108.
    PubMed         Abstract available

  16. LABRECHE C, Cook DP, Abou-Hamad J, Pascoal J, et al
    Periostin gene expression in neu-positive breast cancer cells is regulated by a FGFR signaling cross talk with TGFbeta/PI3K/AKT pathways.
    Breast Cancer Res. 2021;23:107.
    PubMed         Abstract available

  17. BOUCHERON P, Anele A, Zietsman A, Galukande M, et al
    Self-reported arm and shoulder problems in breast cancer survivors in Sub-Saharan Africa: the African Breast Cancer-Disparities in Outcomes cohort study.
    Breast Cancer Res. 2021;23:109.
    PubMed         Abstract available

    Breast Cancer Res Treat

  18. ROTHSCHILD HT, Abel MK, Patterson A, Goodman K, et al
    Obesity and menopausal status impact the features and molecular phenotype of invasive lobular breast cancer.
    Breast Cancer Res Treat. 2021 Nov 24. pii: 10.1007/s10549-021-06453.
    PubMed         Abstract available

  19. SILVER J, Goldenberg A, Moore A
    Dietary supplement use and documentation in a breast cancer survivorship clinic.
    Breast Cancer Res Treat. 2021 Nov 24. pii: 10.1007/s10549-021-06454.
    PubMed         Abstract available

  20. LI Y, Zheng X, Tu D, Ingle JN, et al
    Predicting the clinical outcomes and benefit from letrozole after 5 years of treatment with aromatase inhibitors for early breast cancer: analysis from CCTG MA.17R.
    Breast Cancer Res Treat. 2021 Nov 26. pii: 10.1007/s10549-021-06448.
    PubMed         Abstract available

  21. BARNI S, Cognetti F, Petrelli F
    Is the oncotype DX test useful in elderly breast cancer patients: a subgroup analysis of real-life Italian PONDx study.
    Breast Cancer Res Treat. 2021 Nov 24. pii: 10.1007/s10549-021-06464.
    PubMed         Abstract available

  22. HARBORG S, Ahern TP, Feldt M, Rosendahl AH, et al
    Circulating lipids and breast cancer prognosis in the Malmo diet and cancer study.
    Breast Cancer Res Treat. 2021 Nov 25. pii: 10.1007/s10549-021-06462.
    PubMed         Abstract available

  23. SMALL BJ, Lange M, Zhai W, Ahn J, et al
    Impact of taxane-based chemotherapy among older women with breast cancer on cognition and quality of life: a longitudinal pooled analysis.
    Breast Cancer Res Treat. 2021 Nov 24. pii: 10.1007/s10549-021-06455.
    PubMed         Abstract available

  24. HONKANEN TJ, Luukkainen MEK, Tikkanen A, Karihtala P, et al
    Immune cell profiles of metastatic HER2-positive breast cancer patients according to the sites of metastasis.
    Breast Cancer Res Treat. 2021 Nov 24. pii: 10.1007/s10549-021-06447.
    PubMed         Abstract available

    Breast J

  25. OZMEN V, Ordu C, Ilgun AS, Unal C, et al
    The effects of vitamin D replacement on pathological complete response (pCR) in breast cancer patients receiving neoadjuvant systemic chemotherapy (NAC).
    Breast J. 2021 Nov 21. doi: 10.1111/tbj.14299.


  26. PHILLIPS SM, Penedo FJ, Collins LM, Solk P, et al
    Optimization of a technology-supported physical activity promotion intervention for breast cancer survivors: Results from Fit2Thrive.
    Cancer. 2021 Nov 23. doi: 10.1002/cncr.34012.
    PubMed         Abstract available

    Cancer Epidemiol Biomarkers Prev

  27. BENEFIELD HC, Zirpoli GR, Allott EH, Shan Y, et al
    Epidemiology of Basal-like and Luminal Breast Cancers among Black Women in the AMBER Consortium.
    Cancer Epidemiol Biomarkers Prev. 2021;30:71-79.
    PubMed         Abstract available

  28. SPRAGUE BL, Vacek PM, Mulrow SE, Evans MF, et al
    Collagen Organization in Relation to Ductal Carcinoma In Situ Pathology and Outcomes.
    Cancer Epidemiol Biomarkers Prev. 2021;30:80-88.
    PubMed         Abstract available

  29. NAZARIO CM, Rosario-Rosado RV, Schelske-Santos M, Mansilla-Rivera I, et al
    Sun exposure is associated with reduced breast cancer risk among women living in the Caribbean: The Atabey study in Puerto Rico.
    Cancer Epidemiol Biomarkers Prev. 2021 Nov 22. pii: 1055-9965.EPI-21-0932.
    PubMed         Abstract available

  30. VOHRA SN, Walens A, Hamilton AM, Sherman ME, et al
    Molecular and clinical characterization of postpartum-associated breast cancer in the Carolina Breast Cancer Study Phase I-III, 1993-2013.
    Cancer Epidemiol Biomarkers Prev. 2021 Nov 22. pii: 1055-9965.EPI-21-0940.
    PubMed         Abstract available

    Cancer Lett

  31. CHADELLE L, Liu J, Choesmel-Cadamuro V, Karginov AV, et al
    PKCtheta-mediated serine/threonine phosphorylations of FAK govern adhesion and protrusion dynamics within the lamellipodia of migrating breast cancer cells.
    Cancer Lett. 2021 Nov 23. pii: S0304-3835(21)00599.
    PubMed         Abstract available

    Cancer Res

  32. YUAN H, Yan L, Wu M, Shang Y, et al
    Analysis of the estrogen receptor-associated lncRNA landscape identifies a role for ERLC1 in breast cancer progression.
    Cancer Res. 2021 Nov 22. pii: 0008-5472.CAN-21-1155.
    PubMed         Abstract available


  33. RAHMAN MM, Herath D, Bladen JC, Atkar R, et al
    Differential expression of phosphorylated MEK and ERK correlates with aggressive BCC subtypes.
    Carcinogenesis. 2021;42:975-983.
    PubMed         Abstract available

    Clin Breast Cancer

  34. JOHN P, Osani MC, Kodali A, Buchsbaum R, et al
    Comparative Effectiveness of Adjuvant Chemotherapy in Early-Stage Breast Cancer: A Network Meta-analysis.
    Clin Breast Cancer. 2021;21:e22-e37.
    PubMed         Abstract available

  35. MATHIAS BJ, Sun J, Sun W, Zhou JM, et al
    Surgeon Bias in the Management of Positive Sentinel Lymph Nodes.
    Clin Breast Cancer. 2021;21:74-79.
    PubMed         Abstract available

  36. PATEL BK, Samreen N, Zhou Y, Chen J, et al
    MR Elastography of the Breast: Evolution of Technique, Case Examples, and Future Directions.
    Clin Breast Cancer. 2021;21:e102-e111.
    PubMed         Abstract available

  37. GOFF SL, Danforth DN
    The Role of Immune Cells in Breast Tissue and Immunotherapy for the Treatment of Breast Cancer.
    Clin Breast Cancer. 2021;21:e63-e73.
    PubMed         Abstract available

  38. EARLY AP, Moon W
    Breast Cancer and Secondary Cancer Recurrences After Autologous Tissue Reconstruction.
    Clin Breast Cancer. 2021;21:e96-e101.
    PubMed         Abstract available

  39. GADDAM S, Heller SL, Babb JS, Gao Y, et al
    Male Breast Cancer Risk Assessment and Screening Recommendations in High-Risk Men Who Undergo Genetic Counseling and Multigene Panel Testing.
    Clin Breast Cancer. 2021;21:e74-e79.
    PubMed         Abstract available

  40. RUIZ-CASADO A, Alvarez-Bustos A, de Pedro CG, Mendez-Otero M, et al
    Cancer-related Fatigue in Breast Cancer Survivors: A Review.
    Clin Breast Cancer. 2021;21:10-25.
    PubMed         Abstract available

  41. MCDONOUGH AL, Lei Y, Kwak AH, Haggett DE, et al
    Implementation of a Brief Screening Tool to Identify Needs of Breast Cancer Survivors.
    Clin Breast Cancer. 2021;21:e88-e95.
    PubMed         Abstract available

  42. TUFANO AM, Teplinsky E, Landry CA
    Updates in Neoadjuvant Therapy for Triple Negative Breast Cancer.
    Clin Breast Cancer. 2021;21:1-9.
    PubMed         Abstract available

  43. KIM DW, Kim JS, Kim K, Shin KH, et al
    Spontaneous Rib Fractures After Breast Cancer Treatment Based on Bone Scans: Comparison Of Conventional Versus Hypofractionated Radiotherapy.
    Clin Breast Cancer. 2021;21:e80-e87.
    PubMed         Abstract available

  44. SAYAN M, Vergalasova I, Jhawar S, Kumar S, et al
    Utilization of Hypofractionated Whole-Breast Radiotherapy With Concurrent Anti-Human Epidermal Growth Factor Receptor 2 (HER2) Therapy.
    Clin Breast Cancer. 2021;21:31-36.
    PubMed         Abstract available

  45. PARIS I, Di Giorgio D, Carbognin L, Corrado G, et al
    Pregnancy-Associated Breast Cancer: A Multidisciplinary Approach.
    Clin Breast Cancer. 2021;21:e120-e127.
    PubMed         Abstract available

  46. WAN C, Williams CP, Nipp RD, Pisu M, et al
    Treatment Decision Making and Financial Toxicity in Women With Metastatic Breast Cancer.
    Clin Breast Cancer. 2021;21:37-46.
    PubMed         Abstract available

  47. TSAI ML, Knaack M, Martone P, Krueger J, et al
    Effects of Germline Pathogenic Variants, Cancer Subtypes, Tumor-related Characteristics, and Pregnancy-associated Diagnosis on Outcomes.
    Clin Breast Cancer. 2021;21:47-56.
    PubMed         Abstract available

  48. VILLASCO A, Agnelli F, D'Alonzo M, Accomasso F, et al
    Validation of CTS5 on a Retrospective Cohort of Real-Life Pre- and Postmenopausal Patients Diagnosed With Estrogen Receptor-Positive Breast Cancers: Is It Prognostic?
    Clin Breast Cancer. 2021;21:e53-e62.
    PubMed         Abstract available

  49. SAVVA C, Sadiq M, Sheikh O, Karim S, et al
    Werner Syndrome Protein Expression in Breast Cancer.
    Clin Breast Cancer. 2021;21:57-73.
    PubMed         Abstract available

  50. INUZUKA M, Watanabe C, Yokoyama S, Kuwayama T, et al
    A Retrospective Analysis of the Relationship Between the Result of BRCA1/2 Genetic Testing and Surgical Method Selection in Japan.
    Clin Breast Cancer. 2021;21:e48-e52.
    PubMed         Abstract available

  51. ERNST A, Flynn KE, Weil EM, Crotty BH, et al
    Aromatase Inhibitor Symptom Management Practices: A Retrospective Study.
    Clin Breast Cancer. 2021;21:e38-e47.
    PubMed         Abstract available

  52. LI W, Hu S, Han Z, Jiang X, et al
    YY1-Induced Transcriptional Activation of FAM111B Contributes to the Malignancy of Breast Cancer.
    Clin Breast Cancer. 2021 Oct 29. pii: S1526-8209(21)00298.
    PubMed         Abstract available

  53. MILTON L, Behroozian T, Li N, Zhang L, et al
    Symptom Burden Associated With Radiation Dermatitis in Breast Cancer Patients Undergoing Radiotherapy.
    Clin Breast Cancer. 2021 Oct 13. pii: S1526-8209(21)00296.
    PubMed         Abstract available

  54. BOLUKBASI Y, Oymak E, Sezen D, Onal C, et al
    Hypofractionated Radiation Therapy (HFRT) of Breast/Chest Wall and Regional Nodes in Locally Advanced Breast Cancer: Toxicity Profile and Survival Outcomes in Retrospective Mono-Institutional Study: In Regard to De Matteis et al.
    Clin Breast Cancer. 2021 Oct 28. pii: S1526-8209(21)00303.

  55. YARDLEY DA, Young RR, Adelson KB, Silber AL, et al
    A Phase II Study Evaluating Orteronel, an Inhibitor of Androgen Biosynthesis, in Patients With Androgen Receptor (AR)-Expressing Metastatic Breast Cancer (MBC).
    Clin Breast Cancer. 2021 Oct 28. pii: S1526-8209(21)00302.
    PubMed         Abstract available

    Clin Cancer Res

  56. AUTIO KA, Klebanoff CA, Schaer DA, Kauh JS, et al
    Immunomodulatory Activity of a Colony-Stimulating Factor-1 Receptor Inhibitor in Patients With Advanced Refractory Breast or Prostate Cancer: A Phase 1 Study.
    Clin Cancer Res. 2020 Aug 26. pii: 1078-0432.CCR-20-0855.
    PubMed         Abstract available

  57. TOLANEY SM, Sahebjam S, Le Rhun E, Bachelot T, et al
    A Phase 2 Study of Abemaciclib in Patients with Brain Metastases Secondary to Hormone Receptor Positive Breast Cancer.
    Clin Cancer Res. 2020 Jul 21. pii: 1078-0432.CCR-20-1764.
    PubMed         Abstract available

  58. HUA X, Bi XW, Zhao JL, Shi YX, et al
    Trastuzumab Plus Endocrine Therapy or Chemotherapy as First-line Treatment for Patients with Metastatic Breast Cancer with Hormone Receptor-positive and HER2-positive (SYSUCC-002).
    Clin Cancer Res. 2021 Nov 22. pii: 1078-0432.CCR-21-3435.
    PubMed         Abstract available

    Eur J Cancer

  59. CORTI C, Giachetti PPMB, Eggermont AMM, Delaloge S, et al
    Therapeutic vaccines for breast cancer: Has the time finally come?
    Eur J Cancer. 2021 Nov 22. pii: S0959-8049(21)01185.
    PubMed         Abstract available

  60. SCHNEEWEISS A, Michel LL, Mobus V, Tesch H, et al
    Survival analysis of the randomised phase III GeparOcto trial comparing neoadjuvant chemotherapy of intense dose-dense epirubicin, paclitaxel, cyclophosphamide versus weekly paclitaxel, liposomal doxorubicin (plus carboplatin in triple-negative breast
    Eur J Cancer. 2021 Nov 17. pii: S0959-8049(21)01164.
    PubMed         Abstract available

    Int J Cancer

  61. LOAP P, Loirat D, Berger F, Cao K, et al
    Combination of Olaparib with radiotherapy for triple-negative breast cancers: One-year toxicity report of the RADIOPARP Phase I trial.
    Int J Cancer. 2021;149:1828-1832.
    PubMed         Abstract available

    J Biol Chem

  62. WANG J, Dong Y, Ma H, Wu L, et al
    The Deubiquitinase USP28 Stabilizes Expression of RecQ Family Helicases and Maintains the Viability of Triple Negative Breast Cancer Cells.
    J Biol Chem. 2021 Nov 22:101443. doi: 10.1016/j.jbc.2021.101443.
    PubMed         Abstract available

    J Clin Oncol

  63. JAYASEKERA J, Sparano JA, O'Neill S, Chandler Y, et al
    Development and Validation of a Simulation Model-Based Clinical Decision Tool: Identifying Patients Where 21-Gene Recurrence Score Testing May Change Decisions.
    J Clin Oncol. 2021;39:2893-2902.
    PubMed         Abstract available

    NPJ Breast Cancer

  64. ZERDES I, Simonetti M, Matikas A, Harbers L, et al
    Interplay between copy number alterations and immune profiles in the early breast cancer Scandinavian Breast Group 2004-1 randomized phase II trial: results from a feasibility study.
    NPJ Breast Cancer. 2021;7:144.
    PubMed         Abstract available

  65. MIGLIETTA F, Griguolo G, Bottosso M, Giarratano T, et al
    Author Correction: Evolution of HER2-low expression from primary to recurrent breast cancer.
    NPJ Breast Cancer. 2021;7:149.

  66. PASCUAL T, Oliveira M, Villagrasa P, Ortega V, et al
    Neoadjuvant eribulin in HER2-negative early-stage breast cancer (SOLTI-1007-NeoEribulin): a multicenter, two-cohort, non-randomized phase II trial.
    NPJ Breast Cancer. 2021;7:145.
    PubMed         Abstract available


  67. KONG Y, Zhang Y, Wang H, Kan W, et al
    Inner nuclear membrane protein TMEM201 promotes breast cancer metastasis by positive regulating TGFbeta signaling.
    Oncogene. 2021 Nov 19. pii: 10.1038/s41388-021-02098.
    PubMed         Abstract available

    PLoS One

  68. EASLEY TO, Ren Z, Kim B, Karczmar GS, et al
    Enhancement-constrained acceleration: A robust reconstruction framework in breast DCE-MRI.
    PLoS One. 2021;16:e0258621.
    PubMed         Abstract available

  69. MARRIE RA, Walld R, Bolton JM, Sareen J, et al
    Effect of comorbid mood and anxiety disorders on breast and cervical cancer screening in immune-mediated inflammatory disease.
    PLoS One. 2021;16:e0249809.
    PubMed         Abstract available


  70. TICE JA, Gard CC, Miglioretti DL, Sprague BL, et al
    Comparing Mammographic Density Assessed by Digital Breast Tomosynthesis or Digital Mammography: The Breast Cancer Surveillance Consortium.
    Radiology. 2021 Nov 23:204579. doi: 10.1148/radiol.2021204579.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Breast Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.